Scintimammography (SMM) with 99mTc-MDP: An overview of the experience at the National Cancer Institute of Napoli

Tumori

Volumn 83, Issue 2, 1997, Pages 515-519

  Piccolo, Sergio ^a,b   Lastoria, Secondo ^a   Muto, Pietro ^a   Apicella, Anna ^a   Alaia, Concetta ^a   Petrosino, Teresa ^a   Thomas, Renato ^a   Cortino, Giuseppina ^a   D'Aiuto, Giuseppe ^a   Bazzicalupo, Lucio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

99mTc MDP; Breast cancer; Scintimammography

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CLINICAL PROTOCOL; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SCINTIGRAPHY; SCINTIMAMMOGRAPHY; ARTICLE; BREAST DISEASE; BREAST TUMOR; CARCINOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; ITALY; MAMMOGRAPHY; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE;

EID: 0030610970     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300203     Document Type: Conference Paper

References (32)

1. Adler D.D.: Mammographic evaluation of masses. In: Syllabus: a categorical course in breast imaging Kopans D.B., Mendelson E.B., Eds., pp. 107-116, RSNA Publication, Oak Brook, IL, 1995.
2. Adler L.P., Crowe J.P., AI-Kaisi N.K., Sunshine J.L.: Evaluation of breast masses and axillary lymph nodes with 18-F2-deoxy-2-fluoro-d-glucose PET. Radiology, 187: 743-750, 1993.
3. Azavedo E., Svane G., Auer G.: Stereotactic fine-needle biopsy in 2,594 mammographically detected non palpable lesions. Lancet, 1: 1033-1036, 1989.
4. Ciatto S., Rosselli Del Turco M., Bravetti P.: Nonpalpable breast lesions: stereotaxic fine-needle aspiration cytology. Radiology, 173: 57-59, 1989.
5. Coleman R.E., Rubens R.D., Fogelman I.: Reappraisal of the baseline bone scan in breast cancer. Nucl. Med., 29: 1045-1049, 1988
6. Donegan W.L.: Evaluation of palpable breast masses. N. Engl. J. Med., 327: 937-942, 1992.
7. D'Orsi C.J., Reale F.R., Davis M.A., Brown V.J.: Breast specimens in microcalcifications: radiologic validation and pathologic-radiologic correlation. Radiology, 180: 397-401, 1991.
8. Fajardo L.L., Davis J.R., Wiens J.L., Trego D.C.: Mammography-guided stereotactic fine-needle aspiration cytology of non palpable breast lesions: prospective comparison with surgical biopsy results. A.J.R., 155: 977-981, 1990.
9. Gordon I., Peters A.M., Gutman A., Morony S., Dicks-Mireayx C., Pritchard J.: Technetium-99m bone scans are more sensitive than 1-123-MIBG scans for bone imaging in neuroblastoma. J. Nucl. Med., 31:129-134, 1990.
10. Gordon P.B.: US for problem solving in breast imaging: tricks of the trade. In: Syllabus: a categorical course in breast imaging, Kopans D.B., Mendelson E.B., Eds, pp. 121-131, RSNA Publication, Oak Brook, IL 1995.
11. Holland R., Hendriks J.H.C.L.: Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin. Diagn. Pathol., 11: 181-192, 1994.
12. Kaiser W.A., Zeitler E.: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology, 170: 681-686, 1989.
13. Khalkhali I., Cutrone J.A., Mena I., Diggles L., Venegas R., Vargas H., Jackson B., Klein S.: Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J. Nucl. Med., 36: 1784-1789, 1995.
14. Khalkhali I., Cutrone J.A., Mena I., Diggles L.E., Venegas R.J., Vargas H.I., Jackson B.L., Khalkhali S., Moss J.F., Klein S.R.: Scintimammography: the complementary role of Tc-99m sestaMIBI prone breast imaging for the diagnosis of breast carcinoma. Radiology, 196: 421-426, 1995.
15. Lafontan B., Daures J.P., Salieru B., Eynius F., Mihura J., Rouanet P., Lamarque J.L., Naja A., Pujol H.: Isolated clustered microcalcifications: diagnostic value of mammography - series of 400 cases with surgical verification. Radiology, 190: 479-483, 1994.
16. Lastoria S., Varrelia P., Mainolfi C., Vergara E., Maurea S., Acampa W., Piccolo S., Salvatore M.: Tc-99m sestaMIBI scintigraphy in the diagnosis of primary breast cancer. J. Nucl. Med., 35: 22P, 1994.
17. Lastoria S., Piccolo S., Varrella P., Acampa W., Mainolfi C., Vergara E., Wang H., Muto P., Salvatore M.: Comparative results of technetium-99m MIBI and Technetium-99m methylene diphosphonate scintimammography in patients with breast abnormalities. J. Nucl. Med., 36: 51P, 1995.
18. Lee V.W., Sax E.J., McAneny D.B., Pollack S., Blanchard R.A., Beazley R.M., Kavanah M.T., Ward R.J.: A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J. Nucl. Med., 34: 2095-2100, 1993.
19. Lev-Toaff A.S., Feig S.A., Saitas V.L., Finkel G.C., Schwartz G.F.: Stability of malignant breast microcalcifications. Radiology, 192: 153-156, 1994.
20. Mansi L., Rambaldi P., La Provitera A., Di Gregorio F., Procaccini E.: Technetium-99M tetrofosmin uptake in breast tumors. J. Nucl. Med., 36: 83P, 1995.
21. Maublant J., de Latour M., Mestas D., Clemenson A., Charrier S., Feillel V., Le Bouedec G., Kauffmann P., Dauplat J., Veyrc A.: Technetium-99m-sestaMIBI uptake in breast tumors and associated lymph nodes. J. Nucl. Med., 1996
22. Meyer J.E., Kopans D.B., Stomper P.C., Lindfors K.K.: Occult breast abnormalities: percutaneous preoperative needle localization. Radiology, 150: 335-337, 1984.
23. Moskowitz M.: Minimal breast cancer, redux. Radiol. Clin. North Am., 21: 93-113, 1983.
24. Piccolo S., Lastoria S., Mainolfi C., Muto P., Bazzicalupo L., Salvatore M.: Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J. Nucl. Med., 36: 718-724, 1995.
25. Rosenberg A.L., Schwartz G.F., Feig S.A., Patchefsky A.S.: Clinically occult breast lesions: localizations and significance. Radiology, 162: 167-170, 1987.
26. Ross McDougall I., Pistenma D.A.: Concentration of 99mTc-diphosphonate in breast tissue. Radiology, 112: 655-657, 1974.
27. Sickels E.A.: Breast masses: mammographic evaluation. Radiology, 173: 297-303, 1989.
28. Sickles E.A.: Management of probably benign lesions. In: Syllabus: a categorical course in breast imaging, Kopan D.B., Mendelson E.B., Eds., pp. 133-138, RSNA Publication, Oak Brook, IL, 1995.
29. Taillefer R., Robidoux A., Lambert R., Turpin S., Laperriére J.: Technetium 99m-sestaMIBI prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med., 36: 1758-1765, 1995.
30. Teixidor H.S., Wojsatek D.A., Reiches E.M., Santos-Buch C.A., Minick C.R.: Fine-needle aspiration of breast biopsy specimens: correlation of histologic and cytologic findings. Radiology, 184: 55-58, 1992.
31. Van Eijck C., Krenning E., Bootsama A., Oet H., van Pel R.: Somatostatin receptor scintigraphy in primary breast cancer. Lancet, 343: 640-643, 1994.
32. Waxman A.D., Ramanna L., Memsie L.D., Foster C.E., Silberman A.W., Gleischman S.H., Brenner R.J., Brachman M.B., Kuhar C.J., Yadegar J.: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J. Nucl. Med., 34: 18-23, 1993.